Atyr Pharma, Inc. · NASDAQ:ATYR
BlackRock, Inc. reported a 6.50% stake in Atyr Pharma, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 6.50% stake in Atyr Pharma, Inc., 5,763,606 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 5,763,606
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.50% | 5,763,606 |
Source
Related
- Atyr Pharma, Inc.
- BlackRock, Inc.
- Atyr Pharma, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Jul 8, 2026
- Schedule 13G/A · FMR LLC · Jun 5, 2026
- Form 4 · Schimmel Paul · May 28, 2026